Imaging

12/1/99X-ray right hip: normal
3/1/00MRI: brain: questionable abnormality-repeated in 8 weeks
3/1/00MRI hip—right femoral neck and mid-femur; right acetabulum; scattered throughout osseous of pelvis
May-00CT chest: normal
5/1/00MRI: brain: normal
9/1/00CT chest: negative
9/6/00MRI: hip - extensive metastatic involvement of right femur; patchy metastatic involvement of left femur head and neck
6/1/01CT scan liver had small lesions
6/1/2001–8/01Chemotherapy: AC completed
8/1/01Liver lesions remain: oncologist monitoring
10/22/01CT scan of chest abdomen and pelvis. Decrease nodularity at anterior mediastinum. Probable improvement in hepatic lesions, probable healing and improvement in some bony metastases with exacerbation of others

From: Appendix E: Additional Cases Reviewed

Cover of Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer
Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer.
Evidence Reports/Technology Assessments, No. 78.
Coulter I, Hardy M, Shekelle P, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.